Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Weber

Showing results (301-310 of 316) with videos related to

Pageof 32
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 14, 2017
Reconsidering the causality of TIA1 mutations in ALSRick A van der Spek, Wouter van Rheenen, Sara L Pulit, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Sex-specific DNA methylation differences in Amyotrophic lateral sclerosisOlivia A Grant, Alfredo Iacoangeli, Ramona A J Zwamborn, et al.
Journal of Medical Genetics|April 8, 2014
A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratoriesChizuru Akimoto, Alexander E Volk, Marka van Blitterswijk, et al.
European Journal of Human Genetics : EJHG|June 14, 2012
The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founderBradley N Smith, Stephen Newhouse, Aleksey Shatunov, et al.
Frontiers in Cellular Neuroscience|January 2, 2023
Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence dataAhmad Al Khleifat, Alfredo Iacoangeli, Ashley R Jones, et al.
The Lancet. Neurology|March 31, 2018
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction modelHenk-Jan Westeneng, Thomas P A Debray, Anne E Visser, et al.
NPJ Genomic Medicine|January 29, 2022
Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosisAhmad Al Khleifat, Alfredo Iacoangeli, Joke J F A van Vugt, et al.
The Lancet Regional Health. Europe|February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational studyRené Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 17, 2022
Clinical trials in pediatric ALS: a TRICALS feasibility studyTessa Kliest, Ruben P A Van Eijk, Ammar Al-Chalabi, et al.
Annals of Neurology|December 23, 2011
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosisMichael A van Es, Helenius J Schelhaas, Paul W J van Vught, et al.
Pageof 32

Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 14, 2017
Reconsidering the causality of TIA1 mutations in ALSRick A van der Spek, Wouter van Rheenen, Sara L Pulit, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Sex-specific DNA methylation differences in Amyotrophic lateral sclerosisOlivia A Grant, Alfredo Iacoangeli, Ramona A J Zwamborn, et al.
Journal of Medical Genetics|April 8, 2014
A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratoriesChizuru Akimoto, Alexander E Volk, Marka van Blitterswijk, et al.
European Journal of Human Genetics : EJHG|June 14, 2012
The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founderBradley N Smith, Stephen Newhouse, Aleksey Shatunov, et al.
Frontiers in Cellular Neuroscience|January 2, 2023
Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence dataAhmad Al Khleifat, Alfredo Iacoangeli, Ashley R Jones, et al.
The Lancet. Neurology|March 31, 2018
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction modelHenk-Jan Westeneng, Thomas P A Debray, Anne E Visser, et al.
NPJ Genomic Medicine|January 29, 2022
Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosisAhmad Al Khleifat, Alfredo Iacoangeli, Joke J F A van Vugt, et al.
The Lancet Regional Health. Europe|February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational studyRené Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 17, 2022
Clinical trials in pediatric ALS: a TRICALS feasibility studyTessa Kliest, Ruben P A Van Eijk, Ammar Al-Chalabi, et al.
Annals of Neurology|December 23, 2011
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosisMichael A van Es, Helenius J Schelhaas, Paul W J van Vught, et al.
Pageof 32